Introduction
The history of kidney transplantation is thought to have originated at the early beginning of the previous century with several attempts of Xenografting, and experimental works on vascular sutures (Küss & Bourget, 1992) 1 . But it really started more than 60 years ago with first attempts of deceased donor transplantation (DCD) and the first successful kidney transplantation of homozygote twins in Boston (Toledo-Pereyra et al, 2008) 2 . Belgian surgeons contributed to that field of medicine by performing in the early sixties the first ever organ procurement on a brain dead heart beating donor (DBD) (June 1963) 3 . Later on, in the eighties, they published a first series of living unrelated donor (LURD) transplantations, as well as ABO-Incompatible living donor (ABO-Inc LD) transplantations. With the advent of Cyclosporine A, and later other calcineurin inhibitors such as Tacrolimus, with the advent of more potent immunosuppressive drugs (IS), the gap between the number of renal transplant candidates and the number of transplanted recipients was and is continuously increasing in Belgium and most countries. It opened the search for other sources of organs such as donors after cardiac death (DCD) defined with the Maastricht conference and the extended criteria donors (ECD) compared to standard criteria donors (SCD). In Belgium another source of DCD was identified after the promulgation in 2002 of a law on euthanasia. The Belgian example and all its historical measures could help others to fight against organ shortage and its consequences, organ trafficking, commercialization and tourism. Dog kidney into the neck Developed vascular anastomotic techniques Pig and goat kidneys to the elbow En bloc Maccacus kidneys Nobel price Testis transplantation First deceased donor kidney transplantation Free kidneys from guillotined donors transplanted with surgical techniques still in use today First use of living related donor kidney (mother to son) First transplantation of identical twin kidney (+ first post-transplant pregnancy) (+ TBI: total body irradiation) Successful transplantations of two living related but non-twin kidney allografts (TBI-Steroids) Successful transplantations of two non-related kidney Allografts (TBI-Steroids-6-Mercaptopurine) Xenograft period: 5 en-bloc kidneys from chimpanzees 6 baboon kidneys and 1 liver 1 baboon kidney (54 Liters of urine) First three attempts at orthotopic liver transplantation in humans 25/27 successful renal transplantations with 6-MP First human pancreas transplantation at the University of Minnesota First transplantation of a human heart in Cape Town Table 1 . A timeline in organ transplantation.
In 1909, Ernst Unger used en-bloc Macaccus kidneys in humans which rapidly failed, due to the unknown hyperacute vascular rejection. By contrast, the success of dog autografts at the Mayo Clinic in Rochester helped the transplant physicians to suspect the rejection phenomena; it was also the open door for human kidney homografting. In 1928, Serge Voronoff at the Collège de France in Paris, who was well-known for his monkey to human testis transplantations, was ready to transplant a young girl with renal tuberculosis. The candidate for the organ donation was a murderer condemned to be beheaded, but willing to offer his organs after death. Unfortunately, the Prosecutor of the Republic took a wrong decision and opposed his veto. That's why, only 5 years later, in 1933, another Russian Surgeon, Voronoy, underwent in Kherson, the first ever renal homotransplantation in human using a kidney from a deceased-brain trauma, 60-years-old donor (DCD) (Blood group B). The recipient was a 26-years-old woman (Blood group O), who was dying from acute renal failure due to mercury intoxication. The kidney was placed into the groin (Fig. 5) . Despite the ABO incompatibility, the urine output remained on 5 ml per hour until PO day 2 while the recipient died on PO day 4 with no vascular thrombosis of graft vessels. Later on, David Hume in Boston (1947) and Lawler in Chicago (1950), using again DCD kidney did not encounter better success; they used the Voronoy surgical technique for implantation. In 1951, a further and definitive step was taken in the surgical technique of kidney transplantation, by the French School in Paris. Dubost, OEconomos, Servelle and Rougeulle were using kidneys procured in guillotined murderers; Küss, Teinturier and Millez, used also the Matson kidney (nephrectomy of a normal kidney for ventriculoperitoneal shunt placement to treat hydrocephalia). All kidneys were implanted with the French technique: in the right iliac fossa with vascular anastomosis on the iliac vessels (Fig.  6 ). That technique was used at the Necker Hospital in Paris on Christmas Eve 1952, to transplant Marius Renard with his mother kidney (Fig. 7) . Marius had a single kidney, which had to be removed following a trauma (ladder fall). The mother kidney functioned well without any IS therapy during 3 weeks until rejection occurred, followed by recipient death.
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The procedure developed by Küss and the other French surgeons is currently widely used: it inspired Joseph E. Murray, John Merril and their associates at the Peter Bent Brigham Hospital in Boston with their identical monozygotic twin transplantation, which was first attempted two days before Christmas 1954. The US surgeons proved without any IS agents that living renal transplantation could be safely performed for either the recipient who survived eight years, but also, for the donor (Fig. 8) who recently died at the age of 79 years (Murray, 2011) 6 . Following that attempt, other 19 twin transplantations were successfully performed until 1956 with a 30% recurrence rate of chronic glomerulonephritis (CGN). At that time, the principal ingredients of organ transplantation -immunosuppression, tissue matching, organ procurement and preservation -were still unknown or undeveloped. Therefore, the failure of all other types of grafts, usually resulting in the death of the patient, left little room for optimism (Groth & 
Organ procurement and preservation
The sudden arrival of clinical kidney transplantation during 1962-1963 was so unexpected that little collateral research on the preservation of organs had been done. Kidney transplantation was accomplished at first with total body hypothermia of living volunteer kidney donors using methods developed by cardiac surgeons for open heart operations. In the experimental laboratory, Lillehei et al. simply immersed excised intestine and pancreas in iced saline before its autotransplantation. Thus the principle of hypothermia was understood at an early time, although not efficiently applied 9 . Today, intravascular cooling is the first step in the preservation of all whole organ grafts. The practice was introduced in 1963 of infusing chilled lactated Ringer's or low-molecularweight dextran solutions into the renal artery of kidney grafts immediately after their removal. By late 1981, however, it had become obvious that pancreas, liver and thoracic organ transplant procedures were going to be widely used. Methods of multiple organ procurement were required by which the kidneys, pancreas, liver, heart and lungs or various combinations of these organs could be removed without jeopardizing any of the individual organs 10 . With these methods, all organs to be transplanted are cooled in situ, rapidly removed in a bloodless field, and dissected on a back . Maneuvers for en-bloc removal of a whole pancreas and a liver from a cadaver donor with normal vascular anatomy. The gastroduodenal artery must be divided so that the common and proper hepatic arteries can remain in continuity and be retained with the liver. The portal vein is divided just superior to the entrance of the splenic vein. Then, the pancreatic portion is lengthened by an iliac vein graft. The celiac and superior mesenteric arteries can remain with the pancreas with a Carrel aortic patch 10 .
The ex-vivo perfusion technique also permitted good preservation of kidney or liver allografts. However, the complexity of the method precluded its general use. Thus, it was firstly abandoned in most European kidney transplant centers. A renewal of interest in the perfusion technique resulted from the lack of brain-dead cadaveric donors and the search for other sources such as the non-heart beating donors, or extended criteria donors (ECD). In these types of DCD kidneys, agonic ischemic damages are happening. They could be evaluated by a period of re-conditioning on machine perfusion prior to implantation (Moers et al., 2009) 11 .
The concept of immunosuppression and need for pharmacological agents in transplantation
After Medawar's demonstration in 1944 that rejection was an immunological event, a logical and inevitable question was how to protect the organ allograft by weakening the immune system ( Based upon the demonstration in 1950 that inflammatory diseases could be treated by adrenal steroids, it was natural to apply glucocorticoids to prevent or reserve the severe inflammation of graft rejection. By the late 1950s, the first attempts to use whole body irradiation to prolong transplant survival were also reported (Halloran & Gourishankar, 2001) 13 . But the real IS options that would allow for successful cadaveric transplantation emerged at the end of the 1950s. During that period, Elion and Hitchings developed 6-mercapto-purine (6-MP) and azathioprine (AZA) ( Table 3) . By the early 1960s, the practice of using glucocorticoids in conjunction with AZA had been initiated with high-dose steroid used to reverse rejection. The first application of antilymphocyte globulin (ALG) took place in the 1960s. Efforts at immune cell depletion included thoracic duct drainage, irradiation, thymectomy and splenectomy. 
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In 1963, during a first International Transplantation Congress in Washington, 244 renal allografts were reported. Among them, 28 identical twin transplants. Starlz reported also the first three attempts at orthotopic liver transplantation in humans as well as 25 over 27 successful renal transplantations using 6-MP (Table 1) . With the emerging IS therapy, it was also a period in which attempts of xenografting took place and quickly abandoned. By the late 1970s, the centers that had access to ALG were reporting improved survival rates in kidney transplantation. However, many patients experienced severe steroid side effects. Graft survival remained poor and only kidney transplants were performed in significant numbers with good success 8 . The discovery of cyclosporine (CsA) and its first clinical use in 1978 changed transplantation. Results also improved with widespread access to effective ALG -polyclonal antibodies (Ab) therapy and later with the first monoclonal Ab therapy muromonab-CD3 -, which can reduce reliance on high-dose steroids. Many improvements in medical, surgical, anesthetic, and intensive care management improved clinical results. The growth in transplanting hearts, livers, pancreases and lungs, has created the transplantation programs of the present day. CsA, which blocks the transcriptional activation of IL-2 and others cytokines in T cells, made a significant contribution to the basic science of T cell activation. Tacrolimus (Tac) differed from other drugs in that much that its early development occurred in liver transplants, rather than in kidneys. Acting by the same mechanism as CsA, Tac binds to abundant intracellular protein to create a complex that inhibits the enzyme calcineurin. By the late 1980s, Tac was introduced for use in organ transplants. Today, it is the most common and largely used IS drug. Mycophenolate mofetil (MMF) is an agent derived from the older drug, mycophenolic acid, which is a potent inhibitor of de novo purine synthesis in lymphocytes and highly effective in combination with CsA and Tac in preventing acute rejection in humans. Rapamycin (or Sirolimus-Sir) had been discovered in the 1970s as an antifungal, but the potential of its IS properties for commercial development was not recognized until the late 1980s. Large-scale trials have demonstrated its potential and have led to its recent approval for use in kidney transplantation (Table 3) .
Year
Immunosuppressive Table 3 . A timeline in transplant immunosuppression.
As the third millennium begins, new humanized or chimeric protein products are becoming available (anti-Il2 receptors; anti-CD2; anti-CTL4 Ig; anti-CD3; anti-CD40 ligand; …). Gene therapy and new classes of agents such as FTY720, FK778, peptides and antisense oligonucleotides are currently being evaluated to determine their potential. The new priority is reduction in toxicity with equivalent efficacy. However, immunosuppression would be tailored by better laboratory measurements of the immunological status, ischemic reperfusion injuries, and stability (Halloran & Gourishankar, 2001) 13 . training, first candidates for renal transplantation were maintained on peritoneal dialysis, performed by medical students on a voluntary basis, in 24-hour rotation. On June 3, 1963, a patient was brought in the Emergency Department with a head injury and a profound coma. Despite active resuscitation and vasopressive drugs administration, the patient presented all the signs of what Mollaret had previously described and named "coma dépassé" (Mollaret & Goulon) 15 . Professor Jean Morelle, who was the Chief of the Department of Surgery and also experienced in neurosurgery, took the most important decision of his career: to remove a kidney from that patient while the heart was still beating. Moreover, and by contrast to Professor Hamburger's donor management (Legendre & Kreis, 2010) 16 , they stopped the mechanical ventilation, immediately after kidney procurement, waiting for the heart beat stop in the OR. No preservation fluid was used; the blood contained in the transplant was not even washed away; the graft functioned immediately without any tubular necrosis (Delayed Graft Function) and the patient's serum creatinine normalized in a few days. The patient died on day 87 from sepsis; at that time of death, three other patients had been transplanted with that effective drug IS regimen. The third patient was transplanted with a living donor kidney (patient's uncle) while the fourth, with a cadaver kidney: both had long term function, more than six years. In this way the kidney transplant program of Professor Alexandre was launched. (Table 4 and Table 5 18 . It was also the period during which Mollaret and Goulon proposed the term "coma dépassé" to describe the absence and complete destruction of cerebral functions in order to stop prolonging futile resuscitation (Mollaret & Goulon, 1959) 15 . Even if the concept was admitted in the transplant community, most of the surgeons were waiting for the heart beat stop before starting the procurement (Legendre & Kreis, 2010) 16 . The further step, taken by Professor Alexandre, in disconnecting the body in the OR after the kidney procurement was eventually more difficult to accept. Indeed, even T. Otte, the first heart transplantation by G. Primo (1973) and the first pancreas transplantation by J.P. Squifflet (1982) . Finally, the Belgian Transplantation community had to wait until June 1986 to get a law on Organ Donation and Transplantation. It inc l u d e s a n o p t i n g o u t system. Indeed, the transplant surgeon cannot start any organ procurement if the donor has expressed opposition at the National Registry, or if opposition is communicated in any way to the surgeon. Until 2007, it has been a soft version of the presumed consent principle because a first degree relative could oppose the procurement. A new step was taken in 2007 by suppressing this possibility and therefore turning the presumed consent principle into a strong version. Other important elements of the Belgian Act are that death is not defined -it could be brain death or cardiac death -but must be reported by 3 physicians and violent death must be also reported to the Public prosecutor (Squifflet A.C., 2011) 21 (Tables 4 and 5 ). The women recipient was also one of the first who received cyclosporine A (CsA) as the basic drug in the IS regimen. CsA was used at the dose of 14 mg/kg/day, considered today as a toxic dosage but also in combination with low doses of steroids. The second pancreas transplant was a segmental pancreas transplant alone (PTA). It was performed on a diabetic recipient with pre-end-stage renal failure, in January 1983. Unfortunately, it never functioned due to ischemic damage, pancreatitis and vascular thrombosis. It was promptly removed. By contrast, the first patient rapidly recovered from her double operation; that led to a series of 10 SPK procedures in 10 patients using a segment of pancreas anastomosed to a Roux-en-Y loop. SPK patient number 9 was transplanted in January 86 after chronic rejection of a first cadaver kidney graft. One year later, she delivered a baby girl: she was the third woman ever in the world to enjoy a successful pregnancy after pancreas transplantation. Despite her nephrologist's "disapprobation" she gave birth to a second baby boy in December 1990. 24 . It consists in implanting the whole pancreas with a duodenal segment, with portal drainage (into the superior mesenteric vein) of the venous effluent of the pancreatic graft and exocrine diversion to the recipient duodenum.
The history of Deceased
The latero-lateral duodeno-duodenostomy could be done using running sutures or mechanical staplers (Fig. 12) . 
Current challenges in Donation after Cardiac Death (DCD)
Like in Austria and Spain which have a huge activity in DBD organ procurement, in Belgium it took almost 40 years to start with DCD organ procurement (Squifflet, 2006) 25 . The main reasons are multiple. In 1995, the first international workshop on DCD -during that period, one was speaking of Non-Heart-Beating Donors (NHBD) -took place in Maastricht (The Netherlands) where the 4 categories of DCD were defined and published with 12 statements and recommendations (Kootstra et al., 1995) 26 
As in HBD procedures, the diagnosis of death in a NHBD has to me made by (a) physician (s) independent of the procurement team. 11. Public education and openness concerning NHBD are mandatory to keep public trust and to prevent backfiring on the HBD programs. 12. Opting-out or presumed consent systems allow placement of a preservation device before contact with the family. In countries with opting-in legislation, legal approval for placement of such devices should be sought."
Between 1995 and 2003, the Belgian National Council of Physicians established rules for implementing the DCD program according to the local law. Moreover, all 7 transplant centers had to get a formal approval from their own local Ethical Committee. Finally, it was obvious that such a DCD program could not start without having access to machine perfusion for kidney preservation and re-conditioning. With the help of ET, a large international multicentric study was set up, comparing cold storage and machine perfusion for kidney preservation. In brief, the study demonstrated that 1 year kidney graft survival was 12% higher in recipient of a machine perfused graft which presented a PO delayed graft function (DGF) compared to recipients of a cold storage preserved graft. 27 . That study helped the Belgian Centers to implement the use of DCD without jeopardizing the DBD procurement rate (Fig. 13) . 28 , the use of DCD had as consequence to double the number of donors (Fig. 14 a) , to double the number of kidney transplants (Fig.  14 b) , and to 1 ½ time increase the number of liver transplants (Fig. 14 c) . But it remains several issues to be solved.
The length of the « no touch » period
The Maastricht statement/recommendation n°7 is proposing a 10 min no-touch period after cessation of cardiac massage for Categories II and III. Indeed Category IV does not need a no-touch period as the cardiac arrest is occurring in a DBD. By contrast, 10 min might be too long if one considers that in categories II and III, the brain has already suffered from irreversible injuries. Then, the Pittsburgh School of Medicine protocol proposes a 2 min waiting time (Institute of Medicine, 1997) 29 . Today, there is a national consensus between all Belgian Centers to declare that a no-touch period of 5 minutes could be enough, but it has not been formally set up yet.
The comfort therapy
Even if intensivists are respecting and protecting all dying patients, they agree to avoid futile sufferances while accompanying the patient in his agonic phase. By contrast, others (Feng S., 2010) 30 think that obstacle against administration of drugs could be the logistics of individual and institutional informed consent for the donor and the potential organ recipients. For the above reason, most intensivists are administering what they call a comfort therapy, while withdrawing the unnecessary support. Therefore improved education of health care professionals and providers on the early recognition and special needs of this DCD population i.e. comfort therapy and implementation of clinical protocol should improve the yield of transplantable organs. Aggressive donor protocols will include early aggressive clinical management of DCD donors including comfort therapy. It requires the help of dedicated health care specialists. 
The DCD management: Monitoring awaiting cardiac arrest and drug administration
Unfortunately, today DCD management varies from hospitals to organ procurement organizations, from physicians, nurses, administration and institutional review boards along with donor families (Feng S., 2010) 30 . It is worth remembering that donors are not concentrated in a few hospitals but rather scattered throughout the community. Therefore, a primary barrier to donor management is the need to reach consensus across a broad coalition of parties that stem from distinctive spheres. A second obstacle for making uniform DCD management and drug intervention is the logistics of individual and institutional informed consent for the donor and the potential organ recipients. The definition of human subjects does not encompass DCD after they are legally dead but there is a grey shade period between the decision of stopping futile reanimation with family consent and the recognition of cardiac death, during which DCD management with drug administration takes an important place. That should require the intervention of independent well trained teams working according to ethical consensus and guidelines. The decision of stopping futile reanimation should be taken by 3 physicians, knowing that a small proportion of patients in a vegetative or minimally conscious state have brain activation reflecting some awareness and cognition. Careful clinical examination will result in reclassification of the state of consciousness in some of these patients, in order to avoid subsequent unuseless prolonged warm ischemic time which contra-indicaties DCD organ procurement (Monti et al., 2010) 31 . That should be done according to family wishes. Thereafter, and only thereafter, the DCD organ procurement procedure should be proposed, discussed with the next-of-skin, and informed consent should be obtained. After administration of the comfort therapy (5.4.2.), mechanical ventilation support is withdrawn with or without the endotracheal tube. If extubation is taking place, the tube must be replaced during organ procurement for lungs recovery. Arterial blood pressure is measured via a femoral -better than radial -artery catheter, along with peripheral oxygen saturation (Spo 2 ) and Fio 2 . Systolic blood pressure should decrease lower than 30 mmHg, the heart rate down to zero, along without any Spo 2 waveform. The patient is pronounced dead by the physical examination 5 minutes after the absence of any systemic anterograde blood flow (through the femoral artery catheter) (DuBose and Salim, 2008) 32 . Drug administration, like heparin, is following Ethics guidelines for research with the recently dead (Pentz et al., 2005) 33 .
Brain Death monitoring while waiting cardiac arrest
Current DCD organ procurement procedures make DCD heart graft not suitable for transplantation. Usually, cardiac valves are prepared for homografting. Research is also ongoing and consists in putting the heart graft on normothermic machine perfusion system in order to re-condition the graft during several hours before implantation. Nevertheless, if one could monitor for BD during the DCD procurement procedure, it will allow heart and other organs recovery before waiting for cardiac arrest and the end of the no-touch period, while decreasing the warm ischemic time. The first attempt to monitor a DCD category III, controlled case for BD was done by J.M. Guerit in 2005, using the somatosensory evoked potentials (Guerit et al., 1999) 34 . By the left median nerve monitoring, he observed the disappearance of the P14 wave, while the dropping blood pressure reached the 51/27 mmHg value (Fig. 15) . 
a r a n c e o f B I S . B u t , l i m i t a t i o n s o f B I S a n d electroencephelography are well known, the last one being the worst traditionally recommended tool for BD confirmation (Guerit, 2004) 35 (Guerit, 2006) 36 . Nevertheless, if these observed changes were not due to artefact, dosing of hypnotic or anaesthetic drugs might be warranted (Auyong et al., 2010) 37 . Moreover, it will open doors for recovering more DCD organs including hearts for transplantation. But it will need further manipulations to counteract the agonic phase lesions and ischemic injuries, like the intermediate use of machine perfusion for re-conditioning all grafts.
The living donor (LD) renal transplantation
The first attempt to LD renal transplantation took place as early as 1962 when no IS drugs were available in Belgium. Indeed, it was a first unrelated LD (LURD) kidney graft which rapidly failed (Kinnaert, 2009) 18 . Soon later, Professor Alexandre was more fortunate in performing living donor renal transplantation (LRD) using the Boston IS regimen. In 1968, he added to the IS armentorium the use of homemade antilymphocyte serum. Horses of the Belgian Police Corps and Army, disqualified for duty, were brought to the Hospital laboratories and injected with thoracic duct lymphocytes. These lymphocytes were being collected from recipients of LD kidneys who, in that period of time, were prepared, during 5 days before the operation, with drainage of the thoracic duct (TDD). After immunization, the horses were bled for extracting the antilymphocyte globulins, for injection into the recipients. Later on, Behringwerke Pharmaceuticals (Germany) took over this preparation known as the Behring horse antihuman ALG (Pressimmum ®) which was still in use until the eighties and from which thousands of patients had benefited. Initially ALG was used to treat steroid resistant acute cellular rejections. Since 1976, it had been used as induction therapy along with Aza and steroids. Moreover in LD recipients, a TDD was added to that protocol along with a per-tranplant splenectomy. In October 1982, CsA was combined to that basic IS regimen: that quadruple drug therapy was the reference treatment for more than 10 years. It allowed using low doses of each IS drug, avoiding toxic side-effects, while www.intechopen.com
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hoping an IS synergistic effect (Squifflet et al., 1982) 38 . During the CsA period, for LD transplantation, TDD and splenectomy were abandoned.
The pediatric renal transplantation
The real advantages of using LD kidneys over DBD during the pre CsA era became obvious with the first results obtained in the pediatric population comparing parental to cadaver donation (Fig. 16) (Squifflet et al., 1981) 39 .
Fig. 16. Renal Transplantation in Children.
Graft survival in 32 parental and 35 cadaver graft in pediatric recipients during the pre CsA era (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) . Numbers beside survival curses refer to the number of graft at risk. Difference between the two curses is significant (P < 0.02) and reaches > 30% at 5 years 39 . Fig. 17 . Renal Transplantation. Kidney survival in 56 parental and 26 cadaver graft in pediatric recipients during the CsA era (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) . Difference between the two curves reaches > 30% at 10 years (Malaise et al., 1995) 40 .
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Twenty years later during the CsA era, that was confirmed in the same pediatric population. Surprisingly, the difference in functional survival rates between the 2 subgroups remained similar but it was more than 30% at 10 years, instead of 5 years (Fig. 17) . Even if one year results improved with the CsA use, the slope of the curves were parallel (Malaise et al., 1995) 40 . The children experience underlined the advantages of LD over the DBD renal transplantation. It allows donor selection according to strict medical, serological and anatomical criteria. It insures the quality of the grafts and can help for selection of potential live donors according to the HLA matching (twins, HLA identical siblings, parental…). Moreover the procedure can be programmed without any waiting on dialyse i.e. pre emptive procedure. The recipient can also be prepared by donor specific transfusions and/or pre-transplant IS therapy and/or bone marrow infusion or others. Working in 2 separate operating rooms, it can reduce ischemic injuries with a hemodynamically stable donor. Finally it increases donor self-esteem and the cadaver donor pool.
The Living Unrelated Renal Transplantation (LURD)
In looking at our LD activity (Table.5 and Fig. 18 a and b) The explanation of the phenomena is to be found in looking at mean ages of recipients and donors: for the recipients, it increased from 30 to 50 years and 20 to 40 years for DBD and LD respectively ( Fig. 19 a) ; for the donors, it increased only for DBD from 25 to 40 years but remains stable for LD, around 40 years of age (Fig. 19 b) . One can conclude that our selection criteria for the LD did not change over time; for the aging population of recipients, most of their LRD candidates are not fulfilling the donation criteria. Thus, LURD could be another source for renal transplantation; that source in our program, increased slowly over time (Fig.  20) . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 
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. With the advent of CsA, 41 new LURD were performed between 1983 and 1996, and were compared to paired 82 DBD renal transplantations (Fig. 21) (Malaise et al., 1997) 42 . It is interesting to note that the donor-to-recipient relationship was 22 wife-to-husband, 9 husband-to-wife, 1 aunt-in-law, 1 brother-in-law, 1 wife's niece, 1 mother-in-law, 4 close friends and 2 family's friends. In that series, LURD renal transplantation offered similar results (Fig. 21 a and b) than DBD, despite poorer HLA-A, B and Dr matching and older donor age. The waiting time on dialysis was shorter; early better graft function was encountered in relation to the reduced total ischemia time and better preparation (conditioning) of both donors and recipients. Moreover the video-assisted donor 
The ABO-incompatible (ABO-Inc) living donor renal transplantation
Early in 1981, an ABO-Inc cadaver kidney transplant was accidentally performed (blood group A1 into an O recipient). Despite a rejection crisis on the third week with a sharp increase of the anti-A iso-agglutinins, the renal function completely recovered. The patient survived more than 25 years post-transplantation with a functioning kidney graft. Using a similar approach to that used for achieving ABO-Inc bone marrow transplantation, a series of 39 ABO-Inc live donor kidney transplants (31 related and 8 unrelated donors) was successfully performed (Table 6 ). The recipients received donor-specific platelet transfusions, 3 to 5 plasmapheresis to get rid of the anti-donor iso-agglutinins and underwent splenectomy at the time of transplantation (Alexandre et al., 1985) 44 . Twenty years graft survival is as high as 76% in the youngest recipients (< 15 years) (Squifflet et al., 2004) 45 . It compares favorably with ABO-compatible LD renal transplantation (Fig. 22 a. and b. ). 40 . Fig. 22 . ABO-Inc LRD: 20 years later (Squifflet et al. 2004) 45 .
More surprising is the fact that some patients may carry very high levels of iso-agglutinins with the disappearance of all ABO blood group antigens on the endothelial cells of the transplanted kidney. Later on, Fritz Bach (Bach et al., 1997) 46 proposed the word "accommodation" to name this phenomena; probably there exists a critical period, before the third postoperative week, during which the ABO-Inc transplant is at risk for acute humoral vascular rejection. That is followed by a period of adaptation. Today, more than 20 years later, each part of the original protocol has been further assessed or modified by different groups. Indeed, plasmapheresis was replaced by immuno adsorption columns. For deleting the last circulating iso-agglutinins, high doses of Based on that human experience and using the same preparation, a dozen pig-to-baboon renal xenografts were achieved in the mid-eighties. Three animal recipients survived 10, 22 and 23 days respectively. The baboon who lived for 10 days died of a pulmonary infection: the renal function was normal at the time of death and histology of the xenograft was remarkably normal. Two baboons, who lived for over three weeks, presented an acute rejection crisis at the end of the first week, vascular in nature for the first animal and cellular in the second one. This demonstrated that, together with an appropriate preparation of the donor animal and the recipient, xenotransplantation could be feasible using new potent immunosuppressive drugs. The patient must be an adult or an emancipated minor, capable and conscious at the time of his / her request. The request is made voluntarily, is well thought out and reiterated, and is not the result of outside pressure. The patient is in a hopeless medical condition and complains of constant and unbearable physical or mental pain which cannot be relieved.
Present and future perspectives
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If the person is not in the terminal phase of his illness, the 2 doctors must consult with a third doctor, either a psychiatrist or a specialist in the disease concerned. At least one month must pass between the written request and carrying out the act. Every euthanasia must be reported to a federal commission that regulate the practice and bring prosecutions when necessary. Current statistics demonstrate more than 2 acts per day in Belgium and 7 per day in the Netherlands (Fig.24) . The potential number of patients asking for euthanasia who fulfilled criteria for organ donation will remain limited and was estimated to be between 5 and 10% ( Table 9 . Potential number of patients fulfilling organ donation criteria among Belgian patients requesting euthanasia (Squifflet A.C., 2011) 21 .
period of 3, 1.25 and 1.25 minutes. All 3 hearts were successfully transplanted into 3 children. Therefore, the Denver procedure extends the boundaries of organ donation after circulatory death, and perhaps, will require ethical discussions and revisions of the definition of death. Currently the definition of brain death requires the complete absence of all functions of the entire brain (higher-brain definition). The cardiac definition of death requires the irreversible cessation of cardiac function (impossible to reverse). Based on the Denver procedure, the last definition is not valid anymore. It means also, that in DCD organ procurement, with a neuromonitoring of brain death, and adequate analgesic drug management, cessation of cardiac beats could not be waited for, even without any no-touch period. It will also allow heart procurement, reconditioning on artificial device before implantation.
That will necessitate the revision of the dead donor rule and the endorsement of the DCD procedure by separate well trained teams. The Belgian initiatives in the field of cadaver organ procurement have paid off in terms of number of organs available for allocation. But it remains, like in other countries, that the number of suboptimal organs is increasing for recipients of increasing age and associated morbidities. That will impair the short -and long-term graft and patient outcome.
If there is an urgent need for those centers performing living donor transplantation to turn toward cadaveric organ transplantation, there is also an urgent need for those centers which have DCD programs to turn toward living donor transplantation which offers better results. Current situation prevails: many persons are willing to offer their organs after death in hoping to help their neighbours. Many patients with end-stage renal disease are turning to live donor kidney transplantation to improve survival and quality of life. Many healthy adults are eager and willing to accept the risk of donor nephrectomy to help their loved ones. Therefore, the responsibility is within the medical community to quantify the risks as best as possible and make the information available to those considering donation. That should be considered and will help for avoiding organ trafficking, tourism and commercialisation in the field of renal transplantation.
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